Company: Jazz Pharmaceuticals
Posted by JazzRep_Sleep_Mid_8834 · March 14, 2026
Tags: field, strategy, launch
18 months trying.
heres the truth: only focus on new starts.
stable xyrem patients dont move and fighting them costs more than its worth.
formulary transition argument doesnt land either.
payers in my region havent moved.
home office playbook doesnt account for any of this.
12 upvotes · 6 comments